These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 17148562)

  • 1. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone.
    Hirvikoski T; Nordenström A; Lindholm T; Lindblad F; Ritzén EM; Wedell A; Lajic S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):542-8. PubMed ID: 17148562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-Dimorphic Effects of Prenatal Treatment With Dexamethasone.
    Wallensteen L; Zimmermann M; Thomsen Sandberg M; Gezelius A; Nordenström A; Hirvikoski T; Lajic S
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3838-3846. PubMed ID: 27482827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and social function in girls with congenital adrenal hyperplasia -- influence of prenatally administered dexamethasone.
    Maryniak A; Ginalska-Malinowska M; Bielawska A; Ondruch A
    Child Neuropsychol; 2014; 20(1):60-70. PubMed ID: 23186079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal dexamethasone treatment in the context of at risk CAH pregnancies: Long-term behavioral and cognitive outcome.
    Karlsson L; Nordenström A; Hirvikoski T; Lajic S
    Psychoneuroendocrinology; 2018 May; 91():68-74. PubMed ID: 29529521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive Function of Children and Adolescents With Congenital Adrenal Hyperplasia: Importance of Early Diagnosis.
    Messina V; Karlsson L; Hirvikoski T; Nordenström A; Lajic S
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e683-91. PubMed ID: 31927590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems?
    Hirvikoski T; Nordenström A; Lindholm T; Lindblad F; Ritzén EM; Lajic S
    Eur J Endocrinol; 2008 Sep; 159(3):309-16. PubMed ID: 18579553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study.
    Hirvikoski T; Lindholm T; Lajic S; Nordenström A
    Acta Paediatr; 2011 Sep; 100(9):e112-9. PubMed ID: 21388450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone.
    Meyer-Bahlburg HF; Dolezal C; Baker SW; Carlson AD; Obeid JS; New MI
    J Clin Endocrinol Metab; 2004 Feb; 89(2):610-4. PubMed ID: 14764770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish children and adolescents at risk of congenital adrenal hyperplasia.
    Wallensteen L; Karlsson L; Messina V; Gezelius A; Sandberg MT; Nordenström A; Hirvikoski T; Lajic S
    Horm Behav; 2018 Feb; 98():219-224. PubMed ID: 29410007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good overall behavioural adjustment in children and adolescents with classic congenital adrenal hyperplasia.
    Messina V; Hirvikoski T; Karlsson L; Vissani S; Wallensteen L; Ortolano R; Balsamo A; Nordenström A; Lajic S
    Endocrine; 2020 May; 68(2):427-437. PubMed ID: 32152914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Meyer-Bahlburg HF; Dolezal C; Haggerty R; Silverman M; New MI
    Eur J Endocrinol; 2012 Jul; 167(1):103-10. PubMed ID: 22549088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal endocrine therapy for congenital adrenal hyperplasia should not be done.
    Miller WL
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):469-83. PubMed ID: 26051303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency.
    Lajic S; Nordenström A; Hirvikoski T
    Endocr Dev; 2011; 20():96-105. PubMed ID: 21164263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Trimester DEX Treatment Is Not Associated with Altered Brain Activity During Working Memory Performance in Adults.
    Van't Westeinde A; Zimmermann M; Messina V; Karlsson L; Padilla N; Lajic S
    J Clin Endocrinol Metab; 2020 Nov; 105(11):e4074-82. PubMed ID: 32869847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011).
    Tardy-Guidollet V; Menassa R; Costa JM; David M; Bouvattier-Morel C; Baumann C; Houang M; Lorenzini F; Philip N; Odent S; Guichet A; Morel Y
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1180-8. PubMed ID: 24471566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory Blood Pressure Monitoring in Children and Adults Prenatally Exposed to Dexamethasone Treatment.
    Karlsson L; Wallensteen L; Nordenström A; Krmar RT; Lajic S
    J Clin Endocrinol Metab; 2022 May; 107(6):e2481-e2487. PubMed ID: 35148399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits.
    Miller WL; Witchel SF
    Am J Obstet Gynecol; 2013 May; 208(5):354-9. PubMed ID: 23123167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in adolescents and adults with congenital adrenal hyperplasia.
    Karlsson L; Gezelius A; Nordenström A; Hirvikoski T; Lajic S
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):651-659. PubMed ID: 28771762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RETRACTED: Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish adolescents at risk of CAH.
    Wallensteen L; Zimmermann M; Sandberg MT; Gezelius A; Nordenström A; Hirvikoski T; Lajic S
    Horm Behav; 2016 Sep; 85():5-11. PubMed ID: 27373757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study.
    Amant F; Van Calsteren K; Halaska MJ; Gziri MM; Hui W; Lagae L; Willemsen MA; Kapusta L; Van Calster B; Wouters H; Heyns L; Han SN; Tomek V; Mertens L; Ottevanger PB
    Lancet Oncol; 2012 Mar; 13(3):256-64. PubMed ID: 22326925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.